{"id":10384,"date":"2021-07-12T12:08:30","date_gmt":"2021-07-12T10:08:30","guid":{"rendered":"https:\/\/primaderma.ro\/?page_id=10384"},"modified":"2021-07-15T09:44:41","modified_gmt":"2021-07-15T07:44:41","slug":"dr-brihan-ilarie","status":"publish","type":"page","link":"https:\/\/pdi.ro\/2021\/dr-brihan-ilarie\/","title":{"rendered":"Dr. Brihan Ilarie"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; disabled_on=&#8221;on|off|off&#8221; _builder_version=&#8221;3.22&#8243; custom_margin=&#8221;||&#8221; custom_padding=&#8221;15px||29px&#8221; top_divider_style=&#8221;waves2&#8243; top_divider_color=&#8221;#f0622a&#8221; top_divider_flip=&#8221;horizontal|vertical&#8221; bottom_divider_style=&#8221;waves2&#8243; bottom_divider_color=&#8221;#fcdedb&#8221; bottom_divider_height=&#8221;105px&#8221; bottom_divider_flip=&#8221;vertical&#8221; global_module=&#8221;9062&#8243; collapsed=&#8221;off&#8221;][et_pb_fullwidth_header title=&#8221;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF90aXRsZSIsInNldHRpbmdzIjp7ImJlZm9yZSI6IiIsImFmdGVyIjoiIn19@&#8221; text_orientation=&#8221;right&#8221; header_image_url=&#8221;https:\/\/pdi.ro\/2021\/wp-content\/uploads\/2021\/05\/PDI2021_logo_header_int_600x300px.png&#8221; disabled_on=&#8221;on|on|off&#8221; _builder_version=&#8221;4.9.4&#8243; _dynamic_attributes=&#8221;title&#8221; title_font=&#8221;Kaushan Script||||||||&#8221; title_text_align=&#8221;right&#8221; title_text_color=&#8221;#f0622a&#8221; title_font_size=&#8221;50px&#8221; content_font=&#8221;|600||on|||||&#8221; content_text_align=&#8221;center&#8221; content_text_color=&#8221;#686766&#8243; content_font_size=&#8221;15px&#8221; subhead_font=&#8221;||||||||&#8221; background_color=&#8221;#ef916b&#8221; background_image=&#8221;https:\/\/pdi.ro\/2021\/wp-content\/uploads\/2021\/05\/PDI2021_header_1920x550px.jpg&#8221; background_blend=&#8221;luminosity&#8221; background_layout=&#8221;light&#8221; custom_margin=&#8221;0px||8px&#8221; custom_padding=&#8221;40px||40px||true&#8221; content_font_size_tablet=&#8221;&#8221; content_font_size_phone=&#8221;15px&#8221; content_font_size_last_edited=&#8221;on|desktop&#8221;][\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.4.8&#8243;][et_pb_row column_structure=&#8221;2_5,3_5&#8243; _builder_version=&#8221;3.25&#8243; locked=&#8221;off&#8221;][et_pb_column type=&#8221;2_5&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/pdi.ro\/2021\/wp-content\/uploads\/2021\/07\/Brihan-Ilarie_1-e1626241421432.jpg&#8221; title_text=&#8221;Brihan Ilarie_1&#8243; align=&#8221;center&#8221; align_tablet=&#8221;center&#8221; align_phone=&#8221;&#8221; align_last_edited=&#8221;on|desktop&#8221; _builder_version=&#8221;4.9.7&#8243; max_width=&#8221;25%&#8221; border_radii=&#8221;on|100px|100px|100px|100px&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;3_5&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.9.7&#8243; hover_enabled=&#8221;0&#8243; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h4><span style=\"color: #ff6600;\"><strong><\/strong><\/span><\/h4>\n<h4><span style=\"color: #ff6600;\"><strong>\u0218ef Lucr. Dr. Brihan Ilarie<br \/>Facultatea de Medicin\u0103, Universitatea din Oradea, Rom\u00e2nia<br \/>Spitalul Clinic Jude\u021bean de Urgen\u021b\u0103 Oradea<\/p>\n<p><\/strong><\/span><\/h4>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.9.7&#8243; _module_preset=&#8221;default&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.9.7&#8243; _module_preset=&#8221;default&#8221;][et_pb_text _builder_version=&#8221;4.9.7&#8243; locked=&#8221;off&#8221;]<\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff6600;\">Simpozion Sandoz: Erelzi \u0219i Hyrimoz, dou\u0103 tratamente, un singur dispozitiv, SensoReadyPen<br \/>Lectori: Simona Iano\u0219i, Ilarie Brihan<\/span><\/p>\n<p style=\"text-align: justify;\">Medicamentele biosimilare devin disponibile \u00een diferite arii terapeutice. Un medicament biosimilar este un medicament biologic, care s-a dovedit a nu avea diferen\u021be clinic semnificative fa\u021b\u0103 de medicamentul de referin\u021b\u0103 \u00een ceea ce prive\u0219te calitatea, activitatea biologic\u0103, siguran\u021ba, eficacitatea \u0219i imunogenitatea.1 Medicamentele biosimilare au fost utilizate \u00een practica clinic\u0103 de peste 15 ani ca tratamente pentru \u00eenlocuirea hormonului de cre\u0219tere, pentru neutropenie \u0219i anemie legate de insuficien\u021ba renal\u0103 cronic\u0103 sau de cancer.<br \/>Concuren\u021ba \u00eentre diferite medicamente biologice, inclusiv medicamentele biosimilare, creeaz\u0103 mai multe oportunit\u0103\u021bi de alegere a tratamentului pentru medici \u0219i pentru pacien\u021bi \u0219i \u00eembun\u0103t\u0103\u021be\u0219te performan\u021ba pentru medicamente individuale (cum ar fi dispozitive \u00eembun\u0103t\u0103\u021bite, servicii pentru pacien\u021bi sau formul\u0103ri).<br \/>Prescriptorii ar trebui s\u0103 utilizeze toate dovezile relevante disponibile pentru a lua deciziile privind \u00eengrijirea unui pacient, cu selec\u021bia ini\u021bial\u0103 a celei mai potrivite molecule pe baza considerentelor clinice. Ulterior, medicii care prescriu medicamente ar trebui s\u0103 ia \u00een considerare propunerile de valoare oferite de diferite produse, inclusiv indica\u021biile privind costurile \u0219i licen\u021bele, precum \u0219i al\u021bi factori relevan\u021bi pentru utilizarea produsului \u0219i rezultatele clinice probabile pentru fiecare pacient.<br \/>Produsele biosimilare sunt considerate a fi interschimbabile cu produsul lor de referin\u021b\u0103, ceea ce \u00eenseamn\u0103 c\u0103 un medic poate alege medicamentul biosimilar \u00een locul produsului de referin\u021b\u0103 (sau invers) \u0219i se a\u0219teapt\u0103 s\u0103 ob\u021bin\u0103 acela\u0219i efect clinic (echivalen\u021b\u0103 terapeutic\u0103).1<br \/>Compania Sandoz, care a aniversat anul acesta 15 ani de la producerea primului biosimilar din lume, de hormon de cre\u0219tere (Omnitrope), pune la dispozi\u021bia medicilor \u0219i pacien\u021bilor din Romania un portofoliu complet de biosimilare pentru tratamentul bolilor inflamatorii autoimune, de la adalimumab (Hyrimoz) la etanercept (Erelzi), folosing acela\u0219i dispozitiv inovator de administrare SensoReadyPen, infliximab (Zessly) si rituximab (Rixathon).<\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff6600;\">Simpozion Sandoz: Erelzi and Hyrimoz, two treatments, one device, SensoReadyPen<br \/>Lectori: Simona Iano\u0219i, Ilarie Brihan<\/span><\/p>\n<p style=\"text-align: justify;\">Biosimilar medicines are becoming available across different therapeutic areas. A biosimilar medicine is a biological medicine, which has been shown not to have any clinically meaningful differences from the reference medicine in terms of quality, biological activity, safety, efficacy and immunogenicity.1 Biosimilar medicines have been used in clinical practice for over 15 years as treatments for growth hormone replacement, neutropenia and anemia related to chronic renal failure or cancer.<br \/>Competition between different biological medicines, including biosimilar medicines, creates increased choice for patients and clinicians, and enhanced value propositions for individual medicines (such as improved devices, patient services or formulations).2<br \/>Prescribers should use all available relevant evidence to guide decisions about the care of an individual patient with the initial selection of the most appropriate molecule based on clinical considerations. Subsequently, prescribers should consider the value propositions offered by different products, including cost and licensed indications, as well as other factors relevant to the use of the product and likely clinical outcomes for each patient.<br \/>Biosimilar products are considered interchangeable with their reference product; which means a prescriber can choose the biosimilar medicine over the reference product (or vice versa) and expect to achieve the same clinical effect (therapeutic equivalence)1<br \/>Sandoz with over 15 years experience in producing biosimilars, starting with first worldwide biosimilar, growth hormone (Omnitrope), is offering to doctors and patients in Romania a complete portfolio of biosimilars in inflammatory autoimmune diseases, from adalimumab (Hyrimoz) to etanercept (Erelzi), sharing the same innovative administration device SensoReadyPen, infliximab (Zessly), and rituximab (Rixathon).<\/p>\n<p><!--\n\n<p style=\"text-align: justify;\"><span style=\"color: #ff6600;\">Scurt CV<\/span><\/p>\n\n\n\n\n<p style=\"text-align: justify;\">- absolvent\u0103 a Facult\u0103\u0163ii de Medicin\u0103 General\u0103, Universitatea din Craiova, promo\u0163ia 1995, media 9,92 (Diploma licen\u0163\u0103 nr 266\/28.12.1995).<\/p>\n\n\n\n\n<p style=\"text-align: justify;\">Preg\u0103tirea profesional\u0103 medical\u0103:<br \/>medic rezident neurologie pediatric\u0103 din 1995-1997<br \/>medic rezident dermato-venerologie din 1997-2002<br \/>medic specialist dermato-venerolog \u00een urma examenului sus\u0163inut \u00een martie 2002 (nota 9,69)<br \/>medic primar dermatovenerolog \u00een urma examenului na\u021bional sus\u0163inut \u00een septembrie 2008 (media 9,88) (locul I na\u021bional)<br \/>medic \u0219ef Clinica de dermatologie, Spitalul Clinic Jude\u021bean nr 1 Craiova, 2020<\/p>\n\n\n\n\n<p style=\"text-align: justify;\">Activitatea didactic\u0103:<br \/>preparator prin concurs la disciplina Dermato-venerologie an VI, Universitatea de Medicin\u0103 \u015fi Farmacie din Craiova, 01.10.1997<br \/>asistent universitar la disciplina dermato-venerologie an VI, Universitatea de Medicin\u0103 \u015fi Farmacie din Craiova din 2001<br \/>\u0219ef lucr\u0103ri la disciplina dermato-venerologie din 2009 \u2013 2015<br \/>conferen\u021biar universitar 2015-2020<br \/>profesor universitar din 2021<\/p>\n\n\n\n\n<p style=\"text-align: justify;\">Doctorat \u0219i masterat:<br \/>tez\u0103 doctorat finalizat\u0103 \u00een 2005, U.M.F. Carol Davila, titlul \u201dConsidera\u021bii etiopatogenice \u0219i terapeutice privind sindromul seboreic\u201d, conduc\u0103tor \u0219tiin\u021bific prof. univ. Dr. Dan Forsea;<br \/>masterat \u00een Managementul Unit\u0103\u021bilor Sanitare, U.M.F. din Craiova, 2007-2009<br \/>conduc\u0103tor de doctorat din dec.2019<\/p>\n\n\n\n\n<p style=\"text-align: justify;\">Apartenen\u0103a la societ\u0103\u021bi \u0219tiin\u021bifice sau profesionale de prestigiu din \u021bar\u0103 \u0219i str\u0103inatate:<br \/>Societatea Rom\u00e2n\u0103 de Dermatologie din 1997<br \/>Societatea Rom\u00e2n\u0103 de Dermatologie Filiala Oltenia din 2001<br \/>Membra a \u201eEuropean Academy of Dermato-Venereology\u201d cu numarul O 6924, din 2005<br \/>Societatea Rom\u00e2n\u0103 de Dermato-oncologie \u2013 membru fondator<br \/>Societatea Rom\u00e2n\u0103 de Imuno-dermatologie - membru fondator<\/p>\n\n\n\n\n<p style=\"text-align: justify;\">Lista cu studii \u0219i articole:<br \/>- articole in extenso \u00een reviste indexate ISI si BDI \u201344<br \/>- articole in extenso \u00een reviste cu ISBN\u00a0 - 33<br \/>- articole publicate \u00een rezumat \u00een vol. unor manifest\u0103ri \u0219tiin\u021bifice \u00een \u021bar\u0103 \u2013 222<br \/>- articole publicate \u00een rezumat \u00een vol. unor manifest\u0103ri \u0219tiin\u021bifice \u00een str\u0103inatate \u2013 129<\/p>\n\n\n\n\n<p style=\"text-align: justify;\">Lista cu c\u0103r\u021bile publicate \u20139<br \/>List\u0103 cu congrese \u0219i alte reuniuni \u0219tiin\u021bifice de prestigiu:<br \/>- \u00een \u021bar\u0103 \u2013 86<br \/>- \u00een str\u0103in\u0103tate \u2013 49<\/p>\n\n\n\n\n<p style=\"text-align: justify;\">Cursuri de specializare efectuate \u00een \u021bar\u0103 \u0219i str\u0103in\u0103tate \u2013 17<br \/>Formator cursuri de specialitate pentru medici reziden\u021bi sau speciali\u0219ti dermatologi \u2013 2<br \/>Stagii de preg\u0103tire \u00een \u021bara \u2013 2 \u0219i str\u0103in\u0103tate \u2013 3<br \/>Membru \u00een comitetele \u0219tiin\u021biifice \u0219i de organizare ale unor manifest\u0103ri \u0219tiin\u021bifice na\u021bionale cu\/f\u0103r\u0103 participare interna\u021bional\u0103 \u2013 11<br \/>Membru \u00een comisii na\u021bionale de specialitate organizate de ministerul s\u0103n\u0103t\u0103\u021bii sau \u00eenv\u0103\u021b\u0103m\u00e2ntului \u2013 10<br \/>Pre\u0219edinte \u00een comisii na\u021bionale de specialitate\/primariat organizate de ministerul s\u0103n\u0103t\u0103\u021bii sau \u00eenv\u0103\u021b\u0103m\u00e2ntului - 3<br \/>Director\/responsabil sau membru \u00een granturi\/proiecte na\u021bionale\/interna\u021bionale: 7<br \/>CNCSIS tip A 2007-2008 \u2013 Cercetarea imunohistochimic\u0103 \u015fi pe culturi de celule a interleukinelor proinflamatorii \u015fi rolul lor \u00een etiopatogenia acneei \u2013 \u2013 Beneficiar U.M.F. Craiova, 2007-2008, finan\u0163at cu 179.500 RON, director proiect<br \/>Dezvoltarea dermato-oncologiei ca linie integrat\u0103 de \u00eenv\u0103\u0163\u0103m\u00e2nt superior medical (studii de licen\u0163\u0103 \u015fi masterat) \u015fi a unei re\u0163ele de parteneriat interuniversitare \u00een domeniu\u201d, Beneficiar: U.M.F. \"Carol Davila\" - Centrul de Excelen\u0163\u0103 in Dermatologie, Cod Contract: 56\/1.2\/S\/31081, 2010-2013, 3.850.000 Eur, expert pe termen lung.<br \/>Dezvoltarea unui centru de dermatologie estetic\u0103 \u0219i cercetare medical\u0103, Beneficiar: Centrul Medical dr. Iano\u0219i, Contract nr. 19354\/2010, Planul Opera\u021bional Regional, 2011-2012, 161.000 lei, director proiect<br \/>Algoritm inovativ de diagnostic \u0219i tratament \u00een acnee, Beneficiar: Centrul Medical dr. Iano\u0219i, Contract nr.1433\/ 2012 POS-CCE, 2013-2015, 3.520.000 lei, director proiect<br \/>Dezvoltarea unui centru de proctologie, contract nr POSDRU\/176.3.1\/S\/150319, Beneficiar MC Medica, sept. 2015-dec.2015, membru \u00een echipa de cercetare<br \/>Use of extraglottic and glottic alternative air methods in alternative airway management \u2013 Proiect nr. 2017-1-TR01-K202-046653 Co-funded by the Erasmus+ Programme of the European Union, 103950 Euro, Applicant Organisation \u2013 Amasya University, Turkey, Project partners: Provincial Directorate of Health, Turkey, University of Debrecen, Hungary, University of Craiova, University of Medicina and Pharmacy from Craiova, Romania, 2017-2019 - Membru;<br \/>Dezvoltarea firmei Dr. Iano\u0219i SRL prin achizi\u021bia de aparatur\u0103 \u2013 \u00een cadrul Programului Opera\u021bional Regional 2014-2021, opera\u021biunea 2.2, SMIS 111910 \u2013 2018-2020, 1,2 mil Euro, Beneficiar;<br \/>Studii clinice\/contracte de cercetare interna\u021bionale \u201313<br \/>Studii clinice\/contracte de cercetare na\u021bionale \u2013 7<br \/>Lector invitat\/membru \u00een Advisory Board-uri stiintifice de specialitate regionale\/na\u021bionale cu\/f\u0103r\u0103 participare interna\u021bional\u0103 - 50<br \/>Cit\u0103ri \u00een lucr\u0103ri \u00een sistem ISI \u2013 258 cit\u0103ri, Indice Hirsch= 10<br \/>FCIAP= 22,083<\/p>\n\n-->[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.9.6&#8243; background_color=&#8221;rgba(117,194,33,0.23)&#8221; background_image=&#8221;https:\/\/pdi.ro\/2021\/wp-content\/uploads\/2021\/05\/PDI2021_header_1920x550px.jpg&#8221; background_blend=&#8221;multiply&#8221; custom_padding=&#8221;54px|0px|0|0px|false|false&#8221; top_divider_style=&#8221;waves2&#8243; top_divider_color=&#8221;#ffffff&#8221; top_divider_height=&#8221;155px&#8221; top_divider_height_tablet=&#8221;&#8221; top_divider_height_phone=&#8221;97px&#8221; top_divider_height_last_edited=&#8221;on|desktop&#8221; bottom_divider_style=&#8221;waves2&#8243; bottom_divider_color=&#8221;#75c221&#8243; bottom_divider_flip=&#8221;vertical&#8221; bottom_divider_height_tablet=&#8221;&#8221; bottom_divider_height_phone=&#8221;59px&#8221; bottom_divider_height_last_edited=&#8221;on|desktop&#8221; global_module=&#8221;9177&#8243; saved_tabs=&#8221;all&#8221;][et_pb_row column_structure=&#8221;3_5,2_5&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;61px|0px|69px|0px|false|false&#8221;][et_pb_column type=&#8221;3_5&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.9.4&#8243; text_font=&#8221;Kaushan Script||||||||&#8221; text_text_color=&#8221;#f0622a&#8221; text_font_size=&#8221;30px&#8221; text_line_height=&#8221;1.2em&#8221; header_font=&#8221;||||||||&#8221; background_layout=&#8221;dark&#8221; text_font_size_tablet=&#8221;&#8221; text_font_size_phone=&#8221;&#8221; text_font_size_last_edited=&#8221;on|desktop&#8221;]<\/p>\n<p>Contacteaz\u0103 operatorul PDI 2021<\/p>\n<p>[\/et_pb_text][et_pb_contact_form email=&#8221;contact@pdi.ro\/2021\/2019&#8243; submit_button_text=&#8221;Trimite mesajul&#8221; _builder_version=&#8221;4.9.4&#8243; title_font=&#8221;||||||||&#8221; custom_button=&#8221;on&#8221; button_text_color=&#8221;#F0622A&#8221;][et_pb_contact_field field_id=&#8221;Name&#8221; field_title=&#8221;Nume&#8221; _builder_version=&#8221;3.18.9&#8243; button_text_size__hover_enabled=&#8221;off&#8221; button_one_text_size__hover_enabled=&#8221;off&#8221; button_two_text_size__hover_enabled=&#8221;off&#8221; button_text_color__hover_enabled=&#8221;off&#8221; button_one_text_color__hover_enabled=&#8221;off&#8221; button_two_text_color__hover_enabled=&#8221;off&#8221; button_border_width__hover_enabled=&#8221;off&#8221; button_one_border_width__hover_enabled=&#8221;off&#8221; button_two_border_width__hover_enabled=&#8221;off&#8221; button_border_color__hover_enabled=&#8221;off&#8221; button_one_border_color__hover_enabled=&#8221;off&#8221; button_two_border_color__hover_enabled=&#8221;off&#8221; button_border_radius__hover_enabled=&#8221;off&#8221; button_one_border_radius__hover_enabled=&#8221;off&#8221; button_two_border_radius__hover_enabled=&#8221;off&#8221; button_letter_spacing__hover_enabled=&#8221;off&#8221; button_one_letter_spacing__hover_enabled=&#8221;off&#8221; button_two_letter_spacing__hover_enabled=&#8221;off&#8221; button_bg_color__hover_enabled=&#8221;off&#8221; button_one_bg_color__hover_enabled=&#8221;off&#8221; button_two_bg_color__hover_enabled=&#8221;off&#8221;][\/et_pb_contact_field][et_pb_contact_field field_id=&#8221;Email&#8221; field_title=&#8221;Adresa de e-mail&#8221; field_type=&#8221;email&#8221; _builder_version=&#8221;3.19.4&#8243; button_text_size__hover_enabled=&#8221;off&#8221; button_one_text_size__hover_enabled=&#8221;off&#8221; button_two_text_size__hover_enabled=&#8221;off&#8221; button_text_color__hover_enabled=&#8221;off&#8221; button_one_text_color__hover_enabled=&#8221;off&#8221; button_two_text_color__hover_enabled=&#8221;off&#8221; button_border_width__hover_enabled=&#8221;off&#8221; button_one_border_width__hover_enabled=&#8221;off&#8221; button_two_border_width__hover_enabled=&#8221;off&#8221; button_border_color__hover_enabled=&#8221;off&#8221; button_one_border_color__hover_enabled=&#8221;off&#8221; button_two_border_color__hover_enabled=&#8221;off&#8221; button_border_radius__hover_enabled=&#8221;off&#8221; button_one_border_radius__hover_enabled=&#8221;off&#8221; button_two_border_radius__hover_enabled=&#8221;off&#8221; button_letter_spacing__hover_enabled=&#8221;off&#8221; button_one_letter_spacing__hover_enabled=&#8221;off&#8221; button_two_letter_spacing__hover_enabled=&#8221;off&#8221; button_bg_color__hover_enabled=&#8221;off&#8221; button_one_bg_color__hover_enabled=&#8221;off&#8221; button_two_bg_color__hover_enabled=&#8221;off&#8221;][\/et_pb_contact_field][et_pb_contact_field field_id=&#8221;Message&#8221; field_title=&#8221;Mesajul dvs.&#8221; field_type=&#8221;text&#8221; fullwidth_field=&#8221;on&#8221; _builder_version=&#8221;3.18.9&#8243; button_text_size__hover_enabled=&#8221;off&#8221; button_one_text_size__hover_enabled=&#8221;off&#8221; button_two_text_size__hover_enabled=&#8221;off&#8221; button_text_color__hover_enabled=&#8221;off&#8221; button_one_text_color__hover_enabled=&#8221;off&#8221; button_two_text_color__hover_enabled=&#8221;off&#8221; button_border_width__hover_enabled=&#8221;off&#8221; button_one_border_width__hover_enabled=&#8221;off&#8221; button_two_border_width__hover_enabled=&#8221;off&#8221; button_border_color__hover_enabled=&#8221;off&#8221; button_one_border_color__hover_enabled=&#8221;off&#8221; button_two_border_color__hover_enabled=&#8221;off&#8221; button_border_radius__hover_enabled=&#8221;off&#8221; button_one_border_radius__hover_enabled=&#8221;off&#8221; button_two_border_radius__hover_enabled=&#8221;off&#8221; button_letter_spacing__hover_enabled=&#8221;off&#8221; button_one_letter_spacing__hover_enabled=&#8221;off&#8221; button_two_letter_spacing__hover_enabled=&#8221;off&#8221; button_bg_color__hover_enabled=&#8221;off&#8221; button_one_bg_color__hover_enabled=&#8221;off&#8221; button_two_bg_color__hover_enabled=&#8221;off&#8221;][\/et_pb_contact_field][\/et_pb_contact_form][\/et_pb_column][et_pb_column type=&#8221;2_5&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.9.4&#8243; text_font=&#8221;Kaushan Script||||||||&#8221; text_text_color=&#8221;#f0622a&#8221; text_font_size=&#8221;30px&#8221; header_font=&#8221;||||||||&#8221; background_layout=&#8221;dark&#8221;]<\/p>\n<p>Operatorul PDI 2021<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.0.11&#8243; text_font=&#8221;||||||||&#8221;]<\/p>\n<p><span><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pdi.ro\/2021\/wp-content\/uploads\/2020\/02\/eventer_logo_150px.png\" width=\"151\" height=\"33\" alt=\"\" class=\"wp-image-774 alignleft size-full\" \/><\/span><\/p>\n<p><span><\/span><\/p>\n<p><span><\/span><\/p>\n<p><span>Adresa: Str. A. Panu nr. 13, Iasi<\/span><br \/> <span>Tel.: 0332.40.88.00-05<\/span><br \/> <span>E-mail: <a href=\"mailto:inscrieri@primaderma.ro\" target=\"_blank\" rel=\"noopener noreferrer\">inscrieri@primaderma.ro<\/a><br \/> <\/span><span>Website:\u00a0<\/span><a href=\"http:\/\/www.eventernet.ro\/\" target=\"Blank\" rel=\"noopener noreferrer\">www.eventernet.ro<\/a><\/p>\n<p>[\/et_pb_text][et_pb_text disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.0.11&#8243; text_font=&#8221;Kaushan Script||||||||&#8221; text_text_color=&#8221;#f0622a&#8221; text_font_size=&#8221;30px&#8221; header_font=&#8221;||||||||&#8221; background_layout=&#8221;dark&#8221; locked=&#8221;off&#8221;]<\/p>\n<p>Parteneri Media<\/p>\n<p>[\/et_pb_text][et_pb_gallery gallery_ids=&#8221;7203,7204,9252,9464,10156,10157,10556&#8243; fullwidth=&#8221;on&#8221; _builder_version=&#8221;4.9.7&#8243; transform_scale=&#8221;86%|86%&#8221; max_width=&#8221;63%&#8221; auto=&#8221;on&#8221; auto_speed=&#8221;3500&#8243; hover_transition_duration=&#8221;100ms&#8221; hover_transition_delay=&#8221;50ms&#8221; hover_transition_speed_curve=&#8221;ease-in-out&#8221; locked=&#8221;off&#8221;][\/et_pb_gallery][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u0218ef Lucr. Dr. Brihan IlarieFacultatea de Medicin\u0103, Universitatea din Oradea, Rom\u00e2niaSpitalul Clinic Jude\u021bean de Urgen\u021b\u0103 Oradea &nbsp;Simpozion Sandoz: Erelzi \u0219i Hyrimoz, dou\u0103 tratamente, un singur dispozitiv, SensoReadyPenLectori: Simona Iano\u0219i, Ilarie Brihan Medicamentele biosimilare devin disponibile \u00een diferite arii terapeutice. Un medicament biosimilar este un medicament biologic, care s-a dovedit a nu avea diferen\u021be clinic semnificative [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-10384","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/pages\/10384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/comments?post=10384"}],"version-history":[{"count":7,"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/pages\/10384\/revisions"}],"predecessor-version":[{"id":10569,"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/pages\/10384\/revisions\/10569"}],"wp:attachment":[{"href":"https:\/\/pdi.ro\/2021\/wp-json\/wp\/v2\/media?parent=10384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}